TheProfitWatch

MLTX - MoonLake Immunotherapeutics Class A Ordinary Shares

Day 1m 10m 60m PreMarket Market AfterHours Gap
12.89 -0.13 (-1.05%) 0.0 (-0.04%) 0.01 (0.04%) -0.05 (-0.43%) 0.21 (1.63%) -0.24 (-1.88%) 0.03 (0.23%) 0.16 (1.24%)

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.87
Diluted EPS:
-0.87
Basic P/E:
-14.6609
Diluted P/E:
-14.6609
RSI(14) 1m:
51.14
VWAP:
12.75
RVol:

Events

Period Kind Movement Occurred At

Related News